Skip to main content
Article thumbnail
Location of Repository

DNA Repair in Human Pluripotent Stem Cells Is Distinct from That in Non-Pluripotent Human Cells

By Li Z. Luo, Sailesh Gopalakrishna-Pillai, Stephanie L. Nay, Sang-Won Park, Steven E. Bates, Xianmin Zeng, Linda E. Iverson and Timothy R. O'Connor


The potential for human disease treatment using human pluripotent stem cells, including embryonic stem cells and induced pluripotent stem cells (iPSCs), also carries the risk of added genomic instability. Genomic instability is most often linked to DNA repair deficiencies, which indicates that screening/characterization of possible repair deficiencies in pluripotent human stem cells should be a necessary step prior to their clinical and research use. In this study, a comparison of DNA repair pathways in pluripotent cells, as compared to those in non-pluripotent cells, demonstrated that DNA repair capacities of pluripotent cell lines were more heterogeneous than those of differentiated lines examined and were generally greater. Although pluripotent cells had high DNA repair capacities for nucleotide excision repair, we show that ultraviolet radiation at low fluxes induced an apoptotic response in these cells, while differentiated cells lacked response to this stimulus, and note that pluripotent cells had a similar apoptotic response to alkylating agent damage. This sensitivity of pluripotent cells to damage is notable since viable pluripotent cells exhibit less ultraviolet light-induced DNA damage than do differentiated cells that receive the same flux. In addition, the importance of screening pluripotent cells for DNA repair defects was highlighted by an iPSC line that demonstrated a normal spectral karyotype, but showed both microsatellite instability and reduced DNA repair capacities in three out of four DNA repair pathways examined. Together, these results demonstrate a need to evaluate DNA repair capacities in pluripotent cell lines, in order to characterize their genomic stability, prior to their pre-clinical and clinical use

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (1998). A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
    2. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
    3. (2007). A ROCK inhibitor permits survival of dissociated human embryonic stem cells.
    4. (2009). A simple and efficient cryopreservation method for feeder-free dissociated human induced pluripotent stem cells and human embryonic stem cells.
    5. (2009). A tale of tails: insights into the coordination of 39 end processing during homologous recombination.
    6. (2011). An important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells.
    7. (2010). ATM-independent, highfidelity nonhomologous end joining predominates in human embryonic stem cells. Aging
    8. (2008). Base excision DNA repair.
    9. (2000). Base excision repair in yeast and mammals.
    10. (2009). Base excision repair of oxidative DNA damage and association with cancer and aging.
    11. (2004). BG01V: a variant human embryonic stem cell line which exhibits rapid growth after passaging and reliable dopaminergic differentiation.
    12. (2005). Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation.
    13. (2003). Cell cycle arrest and apoptosis provoked by UV radiation-induced DNA damage are transcriptionally highly divergent responses.
    14. (2003). Cell type-specific hypersensitivity to oxidative damage in CSB and XPA mice.
    15. (2006). Characterization of a new NIH-registered variant human embryonic stem cell line, BG01V: a tool for human embryonic stem cell research.
    16. (1994). Close linkage to chromosome 3p and conservation of ancestral founding haplotype in hereditary nonpolyposis colorectal cancer families.
    17. (1986). Differential DNA repair in transcriptionally active and inactive proto-oncogenes: c-abl and c-mos.
    18. (2010). Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells.
    19. (1994). Disruption of epithelial cell-matrix interactions induces apoptosis.
    20. (2010). DNA damage responses in human induced pluripotent stem cells and embryonic stem cells.
    21. (2010). DNA damage-induced degradation of Cdc25A does not lead to inhibition of Cdk2 activity in mouse embryonic stem cells.
    22. (2000). DNA damageinduced activation of p53 by the checkpoint kinase Chk2.
    23. (2009). DNA repair in mammalian cells: Direct DNA damage reversal: elegant solutions for nasty problems.
    24. (2010). Dynamic dependence on ATR and ATM for double-strand break repair in human embryonic stem cells and neural descendants.
    25. (2004). Effect of Ku86 and DNA-PKcs deficiency on non-homologous end-joining and homologous recombination using a transient transfection assay.
    26. (2003). Efficient repair of cyclobutane pyrimidine dimers at mutational hot spots is restored in complemented Xeroderma pigmentosum group C and trichothiodystrophy/ xeroderma pigmentosum group D cells.
    27. (2002). Embryonic stem cells and somatic cells differ in mutation frequency and type.
    28. (1997). Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts.
    29. (2004). Genetic steps of mammalian homologous repair with distinct mutagenic consequences.
    30. (2005). Genomic alterations in cultured human embryonic stem cells.
    31. (2010). Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence.
    32. (2010). Human embryonic stem cells are capable of executing G1/S checkpoint activation.
    33. (2008). Human Embryonic Stem Cells have Enhanced Repair of Multiple Forms of DNA Damage.
    34. (2010). Identification and classification of chromosomal aberrations in human induced pluripotent stem cells.
    35. (2006). Impaired DNA double strand break repair in cells from Nijmegen breakage syndrome patients.
    36. (2007). Induced pluripotent stem cell lines derived from human somatic cells.
    37. (2009). Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures.
    38. (2009). Inhibition of caspase-mediated anoikis is critical for basic fibroblast growth factor-sustained culture of human pluripotent stem cells.
    39. (2009). Ionizing radiation induces ataxia telangiectasia mutated-dependent checkpoint signaling and G(2) but not G(1) cell cycle arrest in pluripotent human embryonic stem cells.
    40. (2004). Karyotypic stability, genotyping, differentiation, feeder-free maintenance, and gene expression sampling in three human embryonic stem cell lines derived prior to August 9,
    41. (2002). Measurement of UVB-Induced DNA damage and its consequences in models of immunosuppression.
    42. (1989). Methylene blue plus light mediates 8-hydroxyguanine formation in DNA.
    43. (2010). Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis.
    44. (2002). Molecular mechanisms involved in UV-induced apoptotic cell death.
    45. (2006). Molecular mechanisms of mammalian global genome nucleotide excision repair.
    46. (2008). Mouse but not human embryonic stem cells are deficient in rejoining of ionizing radiation-induced DNA double-strand breaks.
    47. (1996). Mutagenesis by thirdstrand-directed psoralen adducts in repair-deficient human cells: high frequency and altered spectrum in a xeroderma pigmentosum variant.
    48. (1993). Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer.
    49. (2010). Oxygen as a friend and enemy: How to combat the mutational potential of 8-oxo-guanine.
    50. (2003). Pathways of DNA double-strand break repair during the mammalian cell cycle.
    51. (1986). Preferential DNA repair of an active gene in human cells.
    52. (2002). Quantitative detection of (125)IdU-induced DNA double-strand breaks with gamma-H2AX antibody.
    53. (2011). Recurrent copy number variations in human induced pluripotent stem cells.
    54. (2007). Repair of alkylated DNA: recent advances.
    55. (2005). Repair of cyclobutane pyrimidine dimers or dimethylsulfate damage in DNA is identical in normal or telomerase-immortalized human skin fibroblasts.
    56. (1977). Repair of ultraviolet light damage in a variety of human fibroblast cell strains.
    57. (2011). Role of oxidative stress and DNA damage in human carcinogenesis.
    58. (1996). Separation of 7-methyl- and 7-(2-hydroxyethyl)-guanine adducts in human DNA samples using a combination of TLC and HPLC.
    59. (2004). Stress defense in murine embryonic stem cells is superior to that of various differentiated murine cells.
    60. (1993). The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer.
    61. (2006). The multifaceted mismatch-repair system.
    62. (2002). The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors.
    63. (1999). The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta.
    64. (1992). Transcription affects the rate but not the extent of repair of cyclobutane pyrimidine dimers in the human adenosine deaminase gene.
    65. (2002). Transcription-coupled nucleotide excision repair as a determinant of cisplatin sensitivity of human cells.
    66. (1977). Two enzymes are required from strand incision in repair of alkylated DNA.
    67. (2001). UV-radiation induces dose-dependent regulation of p53 response and modulates p53-HDM2 interaction in human fibroblasts.
    68. (1999). Xeroderma pigmentosum variant (XP-V) correcting protein from HeLa cells has a thymine dimer bypass DNA polymerase activity.
    69. (2007). XRCC1 down-regulation in human cells leads to DNA-damaging agent hypersensitivity, elevated sister chromatid exchange, and reduced survival of BRCA2 mutant cells.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.